BenevolentAI is the global leader in the development and application of artificial intelligence (“AI”) for scientific innovation. We aim to accelerate the journey from inventive ideas to medicines for patients by developing AI to generate new treatments for some of the world’s 8,000 untreated diseases.
Our team of technologists, AI researchers, and scientists builds and applies AI to the entire drug discovery and development process. The technology unlocks what is not known by creating new ideas based on established facts to provide a different understanding of disease, which leads to inventive steps and real insights that drive the development of new medicines and treatments.
B2B
251 to 500
Series F
$292M
N/A
2013
Healthcare
Biotechnology
Molecule Design
Knowledge & Reasoning
Target Identification
Precision Medicine
Delivering Life Changing Medicines Faster
Analytics
Yes
Active
Machine Learning
Natural Language Processing
Software
AI Scientist
New York, New York
Machine Learning Engineer
New York, New York
Senior AI Scientist
New York, New York
Lead AI Scientist
London, London
Senior Bioinformatics Data Scientist
New York, New York
Want to work at BenevolentAI?
We can introduce you to the right person at BenevolentAI
Interested in what they do or partnership?
Learn more about how they work